Literature DB >> 11716561

Effect of creatine supplementation on metabolite levels in ALS motor cortices.

S Vielhaber1, J Kaufmann, M Kanowski, M Sailer, H Feistner, C Tempelmann, C E Elger, H J Heinze, W S Kunz.   

Abstract

Mitochondrial pathology is an early observation in motor neurons and skeletal muscle of patients with amyotrophic lateral sclerosis (ALS). To clarify the relevance of this finding, we determined the effects of a 1-month oral administration of creatine on (1)H NMR-visible metabolites in the motor cortices of 15 controls and 15 patients with sporadic ALS, most of whom had mitochondrial pathology in skeletal muscle. In the motor cortex of the ALS group the N-acetylaspartate (NAA)/creatine (Cr(t)) metabolite ratio was lower than in our control group, indicating NAA loss. Upon creatine supplementation we observed in the controls a decline in the NAA/Cr(t), NAA/choline (Cho), glutamate + glutamine (Glx)/Cr(t), and Glx/Cho metabolite ratios. In contrast, in the ALS patient group the NAA/Cr(t) and the NAA/Cho metabolite ratios remained unchanged, while the Glx/Cr(t) and Glx/Cho metabolite ratios decreased. These data are compatible with the interpretation that creatine supplementation causes an increase in the diminished NAA levels in ALS motor cortex as well as an increase of choline levels in both ALS and control motor cortices. Because NAA is synthesized by mitochondria in an energy-dependent manner and the NAA/Cho metabolite ratios in the ALS motor cortices were found to be correlated to the degree of mitochondrial pathology in ALS skeletal muscle, our results can be explained by a deficiency of enzymes of mitochondrial respiratory chain in the ALS motor cortex which might affect motor neuron survival. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716561     DOI: 10.1006/exnr.2001.7797

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

Review 1.  Measures and markers in amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Muhammad Qureshi; Jeremy Shefner
Journal:  NeuroRx       Date:  2004-04

2.  Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis.

Authors:  Stefan Sivák; Michal Bittšanský; Egon Kurča; Monika Turčanová-Koprušáková; Milan Grofik; Vladimír Nosál'; Hubert Poláček; Dušan Dobrota
Journal:  Neuroradiology       Date:  2010-04-06       Impact factor: 2.804

3.  Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease?

Authors:  Stefano Belli; Nicola Vanacore
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Cerebral energetic effects of creatine supplementation in humans.

Authors:  J W Pan; K Takahashi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-12-21       Impact factor: 3.619

5.  Creatine supplementation lowers brain glutamate levels in Huntington's disease.

Authors:  Andreas Bender; Dorothee P Auer; Thomas Merl; Ralf Reilmann; Phillip Saemann; Alexander Yassouridis; Julia Bender; Adolf Weindl; Matthias Dose; Thomas Gasser; Thomas Klopstock
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

6.  Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation.

Authors:  Ji-Kyung Choi; Ekkehard Küstermann; Alpaslan Dedeoglu; Bruce G Jenkins
Journal:  Eur J Neurosci       Date:  2009-11-20       Impact factor: 3.386

7.  Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy.

Authors:  Sanjay Kalra; Neil R Cashman; Zografos Caramanos; Angela Genge; Douglas L Arnold
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

Review 8.  International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine.

Authors:  Richard B Kreider; Douglas S Kalman; Jose Antonio; Tim N Ziegenfuss; Robert Wildman; Rick Collins; Darren G Candow; Susan M Kleiner; Anthony L Almada; Hector L Lopez
Journal:  J Int Soc Sports Nutr       Date:  2017-06-13       Impact factor: 5.150

Review 9.  Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis.

Authors:  Miguel Mazón; Juan Francisco Vázquez Costa; Amadeo Ten-Esteve; Luis Martí-Bonmatí
Journal:  Front Neurosci       Date:  2018-10-25       Impact factor: 4.677

10.  Creatine in Health and Disease.

Authors:  Richard B Kreider; Jeffery R Stout
Journal:  Nutrients       Date:  2021-01-29       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.